• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Director Donnelly William P was granted 117 shares, increasing direct ownership by 1% to 9,675 units (SEC Form 4)

    9/30/25 12:06:44 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance
    Get the next $TROW alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    DONNELLY WILLIAM P

    (Last) (First) (Middle)
    C/O T. ROWE PRICE GROUP, INC.
    1307 POINT STREET

    (Street)
    BALTIMORE MD 21231

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    PRICE T ROWE GROUP INC [ TROW ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    09/29/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 09/29/2025 A 117.261(1) A $103.52 9,675.4201 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests.
    Remarks:
    Kathryn L. Reilly, Assistant Corporate Secretary, POA for Donnelly, William P, 09/30/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $TROW alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TROW

    DatePrice TargetRatingAnalyst
    10/3/2025$108.00Market Perform
    BMO Capital Markets
    9/12/2024$109.00Equal Weight
    Wells Fargo
    8/27/2024$99.00Underweight
    Barclays
    4/11/2024$106.00 → $120.00Underperform → Mkt Perform
    Keefe Bruyette
    4/8/2024$92.00 → $114.00Sell → Hold
    TD Cowen
    1/8/2024$95.00 → $105.00Equal Weight → Underweight
    Wells Fargo
    1/4/2024$88.00Underperform
    TD Cowen
    10/31/2023$100.00 → $95.00Sell → Neutral
    Citigroup
    More analyst ratings

    $TROW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on T. Rowe Price with a new price target

    BMO Capital Markets initiated coverage of T. Rowe Price with a rating of Market Perform and set a new price target of $108.00

    10/3/25 8:45:55 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    Wells Fargo initiated coverage on T. Rowe Price with a new price target

    Wells Fargo initiated coverage of T. Rowe Price with a rating of Equal Weight and set a new price target of $109.00

    9/12/24 9:14:34 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    Barclays initiated coverage on T. Rowe Price with a new price target

    Barclays initiated coverage of T. Rowe Price with a rating of Underweight and set a new price target of $99.00

    8/27/24 7:37:56 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    SEC Filings

    View All

    T. Rowe Price Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - PRICE T ROWE GROUP INC (0001113169) (Filer)

    11/3/25 8:39:52 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 10-Q filed by T. Rowe Price Group Inc.

    10-Q - PRICE T ROWE GROUP INC (0001113169) (Filer)

    10/31/25 1:40:17 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. Rowe Price Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - PRICE T ROWE GROUP INC (0001113169) (Filer)

    10/31/25 7:01:49 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    T. ROWE PRICE EXPANDS FIXED INCOME OFFERINGS WITH FOUR NEW ACTIVE ETFS

    The T. Rowe Price Short Municipal Income, Long Municipal Income, High Income Municipal and Multi-Sector Income ETFs began trading today, expanding the firm's ETF lineup to 28 BALTIMORE, Nov. 20, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm and leader in retirement, announced today the addition of four new active fixed income exchange-traded funds (ETF): T. Rowe Price Short Municipal Income ETF (Ticker: TMNS), T. Rowe Price Long Municipal Income ETF (Ticker: TMNL), T. Rowe Price High Income Municipal ETF (Ticker: THYM), and the T. Rowe Price Multi-Sector Income ETF (Ticker: TMSF). The new funds began trading on the NASDAQ exchange today. T. Rowe Pr

    11/20/25 10:00:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. ROWE PRICE EXPERTS SHARE 2026 OUTLOOK FOR GLOBAL FINANCIAL MARKETS

    Though inflation and high valuations remain a concern, the AI boom combined with monetary and fiscal stimulus in the U.S. and an expansionary phase in Europe appears to set the stage for favorable market conditions in 2026. BALTIMORE, Nov. 19, 2025 /PRNewswire/ -- T. Rowe Price held its 43rd annual global market outlook press briefing today, featuring a panel of the firm's investment experts sharing their forecasts for the 2026 global financial markets. Speakers included Tim Murray, capital markets strategist; Josh Nelson, head of Global Equity; Ken Orchard, head of International Fixed Income; Sébastien Page, head of Global Multi-Asset and chief investment officer; and Glenn August, founder

    11/19/25 12:00:00 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Financials

    Live finance-specific insights

    View All

    T. ROWE PRICE GROUP REPORTS THIRD QUARTER 2025 RESULTS

    BALTIMORE, Oct. 31, 2025 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced its financial results for the third quarter of 2025. The earnings release can be found on the firm's website at troweprice.com/newsroom. Chair, Chief Executive Officer, and President Rob Sharps and Chief Financial Officer Jen Dardis will provide an update on business performance, review financial results, and answer questions on a webcast today from 8:00 - 8:45 AM ET. To access the webcast or to obtain dial-in instructions to ask a question, please visit investors.troweprice.com. Sup

    10/31/25 7:00:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. ROWE PRICE GROUP, INC., DECLARES QUARTERLY DIVIDEND

    BALTIMORE, Oct. 28, 2025 /PRNewswire/ -- T. Rowe Price Group (NASDAQ-GS: TROW), a global asset management firm and a leader in retirement, announced today that its Board of Directors has declared a quarterly dividend of $1.27 per share payable on December 30, 2025, to stockholders of record as of the close of business on December 15, 2025. ABOUT T. ROWE PRICE T. Rowe Price (NASDAQ-GS: TROW) is a leading global asset management firm entrusted with managing $1.77 trillion in client assets as of September 30, 2025, about two-thirds of which are retirement-related. Renowned for ov

    10/28/25 12:20:00 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. ROWE PRICE GROUP DECLARES QUARTERLY DIVIDEND

    BALTIMORE, Nov. 1, 2024 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced today that its Board of Directors has declared a quarterly dividend of $1.24 per share payable December 27, 2024, to stockholders of record as of the close of business on December 13, 2024. ABOUT T. ROWE PRICEFounded in 1937, T. Rowe Price (NASDAQ – GS: TROW) helps individuals and institutions around the world achieve their long-term investment goals. As a large global asset management company known for investment excellence, retirement leadership, and independent proprietary research, the firm is built on a culture of integrity that puts client interests first. Clients rely on the award-winning f

    11/1/24 2:35:00 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Leadership Updates

    Live Leadership Updates

    View All

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    T. ROWE PRICE ANNOUNCES CREATION OF GLOBAL STRATEGY FUNCTION

    BALTIMORE, Nov. 13, 2025 /PRNewswire/ -- T. Rowe Price announced today the creation of a Global Strategy function to drive its strategic vision and elevate long-term planning. Andrew Reich will join the firm as head of Global Strategy on January 5, 2026. In this role, Reich will oversee the firm's corporate strategy, corporate development, mergers and acquisitions, and product development. Reich brings deep industry expertise, having most recently served as a partner and head of the Asset Management Practice for North America at McKinsey & Company. During his tenure, he helped

    11/13/25 8:15:00 AM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    T. ROWE PRICE GROUP, INC., DECLARES QUARTERLY DIVIDEND AND ANNOUNCES ANNUAL MEETING VOTING RESULTS

    BALTIMORE, May 9, 2025 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced today that its Board of Directors has declared a quarterly dividend of $1.27 per share payable June 27, 2025, to stockholders of record as of the close of business on June 13, 2025. Additionally, at its annual meeting yesterday, T. Rowe Price Group, Inc.'s stockholders: Elected 11 directors to its Board of Directors;Approved, by a nonbinding advisory vote, the compensation paid by the Company to its Named Executive Officers;Ratified the appointment of KPMG LLP as the Company's indepen

    5/9/25 1:25:00 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Verma Richard R. was granted 2,859 shares (SEC Form 4)

    4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

    10/29/25 12:16:47 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    Director Golston Allan C. was granted 2,859 shares (SEC Form 4)

    4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

    10/29/25 12:16:28 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 3 filed by new insider Verma Richard R.

    3 - PRICE T ROWE GROUP INC (0001113169) (Issuer)

    10/20/25 12:25:03 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    $TROW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by T. Rowe Price Group Inc. (Amendment)

    SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)

    2/13/24 4:55:53 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by T. Rowe Price Group Inc. (Amendment)

    SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)

    1/29/24 12:09:07 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by T. Rowe Price Group Inc. (Amendment)

    SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)

    2/10/23 12:26:32 PM ET
    $TROW
    Investment Bankers/Brokers/Service
    Finance